Canada Life
RLAY icon

Canada Life’s Relay Therapeutics RLAY Stock Holding History

Canada Life’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86K Hold
8,624
– – ﹤0.01% 1708
2025
Q4 		$73K Hold
8,624
– – ﹤0.01% 1754
2025
Q3 		$45K Hold
8,624
– – ﹤0.01% 1820
2025
Q2 		$30K Hold
8,624
– – ﹤0.01% 1864
2025
Q1 		$23K Hold
8,624
– – ﹤0.01% 1922
2024
Q4 		$36K Hold
8,624
– – ﹤0.01% 1912
2024
Q3 		$61K Hold
8,624
– – ﹤0.01% 1929
2024
Q2 		$56K Hold
8,624
– – ﹤0.01% 1957
2024
Q1 		$71K Hold
8,624
– – ﹤0.01% 1982
2023
Q4 		$94K Hold
8,624
– – ﹤0.01% 1959
2023
Q3 		$72K Buy
8,624
+5,229
+154% +$56.2K ﹤0.01% 2028
2023
Q2 		$43K Hold
3,395
– – ﹤0.01% 2018
2023
Q1 		$56K Sell
3,395
-1,004
-23% -$18K ﹤0.01% 2053
2022
Q4 		$66K Buy
4,399
+891
+25% +$17.1K ﹤0.01% 2046
2022
Q3 		$78K Hold
3,508
– – ﹤0.01% 2032
2022
Q2 		$59K Buy
3,508
+1,014
+41% +$21.7K ﹤0.01% 2028
2022
Q1 		$79K Buy
2,494
+819
+49% +$19.9K ﹤0.01% 2051
2021
Q4 		$51K Hold
1,675
– – ﹤0.01% 2165
2021
Q3 		$53K Hold
1,675
– – ﹤0.01% 2222
2021
Q2 		$61K Hold
1,675
– – ﹤0.01% 2211
2021
Q1 		$57K Hold
1,675
– – ﹤0.01% 2256
2020
Q4 		$69K Buy
+1,675
New +$75.7K ﹤0.01% 2187

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Canada Life's RLAY Position: Q1 2026 in Review

Canada Life held its Relay Therapeutics (RLAY) position steady in Q1 2026 at 8,624 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Canada Life first reported a position in RLAY in Q4 2020 and has held it in 22 quarters since. The position peaked at $94K in Q4 2023. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Canada Life held 8,624 shares of Relay Therapeutics worth $86K as of Q1 2026.
  • Canada Life left its Relay Therapeutics share count unchanged in Q1 2026.
  • Relay Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1708 holding.
  • Canada Life first reported a position in Relay Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Canada Life's Relay Therapeutics position peaked at $94K in Q4 2023.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.